Literature DB >> 29634672

Experimental Evidence of the Healing Properties of Lactobionic Acid for Ocular Surface Disease.

Melania Olivieri1, Martina Cristaldi1, Salvatore Pezzino1, Gabriella Lupo2, Carmelina Daniela Anfuso2, Caterina Gagliano3, Carlo Genovese4,5, Dario Rusciano1.   

Abstract

PURPOSE: The aim of this study was to investigate the properties of lactobionic acid (LA) as a possible supplement in artificial tears in in vitro and in vivo experimental model systems. LA is a bionic derivative of a polyhydroxy acid, which consists of one galactose attached by an ether link to a gluconic acid. It is a molecule endowed with several properties that make it an ideal supplement in artificial tears: it is highly hygroscopic and a powerful antioxidant, it is an iron chelator and inhibits matrix metalloprotease activity; it favors wound healing (WH); and it inhibits bacterial growth.
METHODS: Promotion of WH by LA, alone or in combination with hyaluronic acid (HA), was investigated in vitro on monolayers of rabbit corneal cells (Statens Seruminstitut) and in vivo after epithelium debridement of rabbit corneas. TGF-β expression and MMP-9 activity in wounded corneas were detected in tears and cornea extracts by western blot or by Enzyme Linked ImmunoSorbent Assay (ELISA). Bacterial growth inhibition by LA was checked on Staphylococcus aureus isolates in liquid culture.
RESULTS: LA, with or without HA, favors WH in vitro and in vivo. The WH assay on the rabbit cornea showed that 4% LA in association with 0.15% HA also resulted in a blunted increase of MMP-9 and TGF-β in tears and corneal tissue. Finally, the presence of 4% LA resulted in slower growth of cultured bacterial isolates.
CONCLUSIONS: Our findings support the hypothesis that LA could be a useful supplement to artificial tears to treat ocular surface dysfunction such as dry eye.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29634672     DOI: 10.1097/ICO.0000000000001594

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  3 in total

1.  Antibacterial activity and mechanism of lactobionic acid against Staphylococcus aureus.

Authors:  Jiarong Cao; Hongjie Fu; Lihong Gao; Yan Zheng
Journal:  Folia Microbiol (Praha)       Date:  2019-04-16       Impact factor: 2.099

2.  Rapha Myr®, a Blend of Sulforaphane and Myrosinase, Exerts Antitumor and Anoikis-Sensitizing Effects on Human Astrocytoma Cells Modulating Sirtuins and DNA Methylation.

Authors:  Barbara Tomasello; Maria Domenica Di Mauro; Giuseppe Antonio Malfa; Rosaria Acquaviva; Fulvia Sinatra; Giorgia Spampinato; Samuele Laudani; Giusy Villaggio; Anna Bielak-Zmijewska; Wioleta Grabowska; Ignazio Alberto Barbagallo; Maria Teresa Liuzzo; Elisabetta Sbisà; Maria Grazia Forte; Claudia Di Giacomo; Massimo Bonucci; Marcella Renis
Journal:  Int J Mol Sci       Date:  2020-07-27       Impact factor: 5.923

Review 3.  Is dry eye disease the same in young and old patients? A narrative review of the literature.

Authors:  Stefano Barabino
Journal:  BMC Ophthalmol       Date:  2022-02-22       Impact factor: 2.209

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.